FDA recalls thousands of blood pressure bottles after it failed quality tests
The FDA has issued a Class II recall for thousands of blood pressure medication bottles produced by Macleods Pharma USA due to quality control failures. The affected tablets failed to dissolve properly during testing, posing potential health risks to consumers.
Why it matters
Public health safety is critical, and this recall affects patients relying on medication for chronic conditions.
The U.S. Food and Drug Administration is asking consumers to check their medicine cabinets after thousands of blood pressure medication bottles were recalled nationwide. According to the FDA's website, New Jersey-based Macleods Pharma USA is recalling certain lots of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets. The recall was issued on Oct. 7, 2026, with the FDA later instituting a Class II rating on Oct. 26, 2026. A Class II recall means the use of the affected medication may cause "temporary or medically reversible adverse health consequences."
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in